Achieve Life Sciences, Inc. (ACHV) — 10-Q Filings

10-Q Filings (6)

• ACHV's Losses Widen Amid Soaring R&D, Admin Costs — Nov 6, 2025 Risk: high
  Achieve Life Sciences, Inc. (ACHV) reported a significant increase in net loss and operating expenses for the nine months ended September 30, 2025, compared to
• ACHV Losses Widen, Raises $10M in Public Offering — Aug 7, 2025 Risk: high
  ACHIEVE LIFE SCIENCES, INC. reported a net loss of $10.2 million for the three months ended June 30, 2025, compared to a net loss of $9.5 million for the same p
• Achieve Life Sciences Files Q1 2025 10-Q — May 13, 2025 Risk: medium
  Achieve Life Sciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Sonus Pharmaceuticals Inc. and Oncogenex Pharmac
• Achieve Life Sciences Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Achieve Life Sciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial position and business operations, inc
• Achieve Life Sciences Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Achieve Life Sciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition and business operations, includi
• ACHV Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  ACHIEVE LIFE SCIENCES, INC. (ACHV) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. ACHV filed a 10-Q for the period ending March 31, 2024. The fili

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX